Arnaud DELOBEL, R&D Director, Quality Assistance
Webinar held on 23rd May 2019.
Absolute quantification of proteins (i.e. quantification without the need for a reference standard) is a key analysis for the qualification of reference standards or to determine the extinction coefficient of a protein. It is usually performed using amino acid analysis, but this technique shows limited accuracy and repeatability.
Quality Assistance has developed an innovative method based on the quantification of sulphur by isotope dilution ICP/MS. Unprecedented precision and accuracy can be obtained, which provides a reliable quantification of proteins and determination of extinction coefficients.
During this webinar, we outlined the steps we took to successfully develop this test solution, the results of the validation study, and the application of the method to monoclonal antibodies and antibody-drug conjugates.
This method was recently nominated for the essenscia Innovation Award and included in the list of 5 high-potential innovations.
Access this 45-minutes-webinar to learn how ICP/MS can be used for the absolute quantification of proteins, with precision and accuracy that cannot be reached with amino acid analysis. After a description of the development and validation of the method, its application to monoclonal antibodies and antibody-drug conjugates were presented.
Visit www.quality-assistance.com for more information.
Synthesis of 2-aminocyclopent-1-ene-1-carbodithioic acid (ACA) Capped Silver ...IJERA Editor
The present work deals with the formation, morphology and photophysical activity of the 2-aminocyclopent-1-ene-1-carbodithioic acid (ACA) Capped Silver nanoparticles via chemical reduction method. The method utilizes a simple chemical reaction of silver idodide and sodium borohydride. The advantages of this method are ease of preparation, convenience in use and especially, that the obtained silver nano particles are uniform in their shapes and sizes. This is important for fluorescence & bio-evolution measurements. Furthermore, UV-visible (UV-vis) spectroscopy is employed to monitor the formation process of the nano particles and to determine the optimum conditions for the preparation of stable and highly fluorescence-active silver colloids. Specifically, we observed changes in the shapes of the silver nano particles during the formation. This may be helpful in understanding the growth of the nano particles and creates a new dimension in controlling the shapes of the nano particles.SEM, TEM and XRD studies are carried out. The suitability of ACA capped Ag-NPs as Biomarkers is also Tested by Fluorescence study.
Exploring the Versatility of Micro-flow Technology – From Peptide Biomarkers ...Waters Corporation
Presenter: Corey D. Broeckling, Ph.D., Associate Director, Proteomics and Metabolomics Facility, Joint Assistant Professor, Colorado State University
Microfluidic technology offers multiple advantages including ease of use, robustness and sensitivity. Coupled with a tandem quadrupole mass spectrometer (such as the Xevo TQ-S) we can create an optimal and versatile “middle ground” platform in which these advantages can be exploited for both small molecule and peptide quantitative applications. For example, most small molecule applications are performed using standard flow chromatography (in the range of 600-100 L/min) consuming a high level of both solvent and sample which increases the cost (both fiscally and environmentally). The use of microfluidic technology for these small molecule applications can reduce solvent consumption by upwards of 150-fold and can significantly increase on-column sensitivity, thus reducing sample consumption. Conversely, quantitative peptide assays are almost exclusively performed using nanoscale chromatography (~400 nL/min) to achieve the required sensitivity for detection of these low abundance molecules within a complex matrix (e.g. serum, urine, etc.). We have found that the use of microfluidic technology for peptide quantitation yields the same or better sensitivity when compared to a nanoscale platform and has the additional, very significant advantages of ease of use, robustness, and improved chromatographic resolution (e.g. peak capacity). Thus, with a single analytical platform we can perform quantitative analysis for a wide range of compounds spanning from lipids/metabolites to peptides. One application in which the technology has struggled is the analysis of compounds in negative ionization mode. This limitation has been overcome in the development of a next generation microfluidic device that incorporates post-column addition of isopropanol to improve ionization and spray stability in negative mode applications. With this new capability we can now perform quantitative experiments in negative mode or with polarity switching.
This presentation was given at the 11th International Conference of the Metabolomics Society (Metabolomics 2015, #metsoc2015 on Twitter), June 29, 2015, in San Francisco.
Austin Biomolecules: open access is a peer reviewed, scholarly journal dedicated to publish articles covering all areas of Biomolecules.
The journal aims to promote latest information and provide a forum for doctors, researchers, physicians, and healthcare professionals to find most recent advances in the areas of Biomolecules. Austin Biomolecules: open access accepts research articles, reviews, mini reviews, case reports and rapid communications covering all aspects of Biomolecules.
Austin Biomolecules: open access strongly supports the scientific up gradation and fortification in related scientific research community by enhancing access to peer reviewed scientific literary works. Austin Publishing Group also brings universally peer reviewed journals under one roof thereby promoting knowledge sharing, mutual promotion of multidisciplinary science.
Improving Downstream Processing: Application of Excipients in DSPMilliporeSigma
Webinar summary:
This webinar will showcase the beneficial potential of using excipients during downstream processing of monoclonal antibodies.
Learning points:
In this webinar, you will see:
* An innovative excipient screening approach simulating low pH stress conditions during protein A chromatography and virus inactivation
* How the application of excipients in buffer systems can significantly improve protein stability and chromatographic performance
Abstract:
Key aspects during downstream purification of biopharmaceutical drugs are purity and process yield. Therefore, the downstream process needs to be designed in a way that the final product which will eventually end up in the patient entails low levels of product- and process related impurities (e.g. high molecular weight aggregates) as well as process related contaminants (e.g. host cell protein levels). In addition to this, the process must be capable of clearing and inactivating viruses to ensure product safety. In this webinar, we will explore the benefits of adding excipients during downstream processing on protein stability, chromatographic performance and viral inactivation.
Dark fermentative hydrogen production is an intermediate microbial process occurring along anaerobic microbial degradation of organic matter. One direct application of this fermentative bioprocess consists in the production of renewable H2 and simultaneous treatment of organic pollutants. Nowadays, high amounts of saline effluents are generated by fish, seafood, petroleum and leather industries. Such saline effluents are rarely treated by biological anaerobic processes that are strongly inhibited by high salt concentrations. Alternative biological processes, such as dark fermentation, still remain to be investigated with the aim of removing organic pollution from such saline effluents. Moreover, more knowledge about the effect of saline conditions on fermentative microbial mixed cultures would provide new insights on the bacterial inhibition resulting from their exposition to saline conditions.
This study deals with the characterization of hydrogen-producing microbial communities after increasing salt concentrations in a range compatible with a marine environment.
A series of batch experiments was performed under anaerobic conditions favorable to hydrogen production, with a NaCl concentration ranging from 9 to 75 gNaCl/L. Marine sediments were used as inoculum. Biogas and bacterial metabolites were monitored over experimental time. The bacterial community structure dynamics were characterized using molecular tools based on the analysis of genomic 16S rDNA (CE-SSCP), and individual bacterial species were further identified by pyrosequencing.
As a result, the significant and highest biohydrogen production yield (0.9±0.04 molH2.molGlucose-1) was observed at the highest NaCl concentration of 75 g.L-1. However, by increasing the NaCl concentration, the bioH2 production rates slowed down gradually, and longer lag phases were observed. A clear and gradual metabolic shift was also observed suggesting a substantial impact of the saline environment on anaerobic bacterial metabolism, as well as a high selection pressure on acidogenic bacteria. As expected, the composition of the bacterial community at 9gNaCl/L (control) was consistent with literature data, with Clostridium sp. and Enterobacter sp as main dominant species. Interestingly, a gradual shift of the bacterial community structure, concomitant to metabolic changes, was observed by increasing NaCl concentration, with Vibrio sp. as new dominant bacteria (87% in abundance) at the highest salinities. This is the first report on the presence of Vibrio sp. as main hydrogen-producing bacteria in such acidogenic mixed-cultures.
Thus, this study provides new insights on anaerobic metabolism occurring in saline conditions with new possibilities of biotechnological applications from such saline effluents.
Synthesis of 2-aminocyclopent-1-ene-1-carbodithioic acid (ACA) Capped Silver ...IJERA Editor
The present work deals with the formation, morphology and photophysical activity of the 2-aminocyclopent-1-ene-1-carbodithioic acid (ACA) Capped Silver nanoparticles via chemical reduction method. The method utilizes a simple chemical reaction of silver idodide and sodium borohydride. The advantages of this method are ease of preparation, convenience in use and especially, that the obtained silver nano particles are uniform in their shapes and sizes. This is important for fluorescence & bio-evolution measurements. Furthermore, UV-visible (UV-vis) spectroscopy is employed to monitor the formation process of the nano particles and to determine the optimum conditions for the preparation of stable and highly fluorescence-active silver colloids. Specifically, we observed changes in the shapes of the silver nano particles during the formation. This may be helpful in understanding the growth of the nano particles and creates a new dimension in controlling the shapes of the nano particles.SEM, TEM and XRD studies are carried out. The suitability of ACA capped Ag-NPs as Biomarkers is also Tested by Fluorescence study.
Exploring the Versatility of Micro-flow Technology – From Peptide Biomarkers ...Waters Corporation
Presenter: Corey D. Broeckling, Ph.D., Associate Director, Proteomics and Metabolomics Facility, Joint Assistant Professor, Colorado State University
Microfluidic technology offers multiple advantages including ease of use, robustness and sensitivity. Coupled with a tandem quadrupole mass spectrometer (such as the Xevo TQ-S) we can create an optimal and versatile “middle ground” platform in which these advantages can be exploited for both small molecule and peptide quantitative applications. For example, most small molecule applications are performed using standard flow chromatography (in the range of 600-100 L/min) consuming a high level of both solvent and sample which increases the cost (both fiscally and environmentally). The use of microfluidic technology for these small molecule applications can reduce solvent consumption by upwards of 150-fold and can significantly increase on-column sensitivity, thus reducing sample consumption. Conversely, quantitative peptide assays are almost exclusively performed using nanoscale chromatography (~400 nL/min) to achieve the required sensitivity for detection of these low abundance molecules within a complex matrix (e.g. serum, urine, etc.). We have found that the use of microfluidic technology for peptide quantitation yields the same or better sensitivity when compared to a nanoscale platform and has the additional, very significant advantages of ease of use, robustness, and improved chromatographic resolution (e.g. peak capacity). Thus, with a single analytical platform we can perform quantitative analysis for a wide range of compounds spanning from lipids/metabolites to peptides. One application in which the technology has struggled is the analysis of compounds in negative ionization mode. This limitation has been overcome in the development of a next generation microfluidic device that incorporates post-column addition of isopropanol to improve ionization and spray stability in negative mode applications. With this new capability we can now perform quantitative experiments in negative mode or with polarity switching.
This presentation was given at the 11th International Conference of the Metabolomics Society (Metabolomics 2015, #metsoc2015 on Twitter), June 29, 2015, in San Francisco.
Austin Biomolecules: open access is a peer reviewed, scholarly journal dedicated to publish articles covering all areas of Biomolecules.
The journal aims to promote latest information and provide a forum for doctors, researchers, physicians, and healthcare professionals to find most recent advances in the areas of Biomolecules. Austin Biomolecules: open access accepts research articles, reviews, mini reviews, case reports and rapid communications covering all aspects of Biomolecules.
Austin Biomolecules: open access strongly supports the scientific up gradation and fortification in related scientific research community by enhancing access to peer reviewed scientific literary works. Austin Publishing Group also brings universally peer reviewed journals under one roof thereby promoting knowledge sharing, mutual promotion of multidisciplinary science.
Improving Downstream Processing: Application of Excipients in DSPMilliporeSigma
Webinar summary:
This webinar will showcase the beneficial potential of using excipients during downstream processing of monoclonal antibodies.
Learning points:
In this webinar, you will see:
* An innovative excipient screening approach simulating low pH stress conditions during protein A chromatography and virus inactivation
* How the application of excipients in buffer systems can significantly improve protein stability and chromatographic performance
Abstract:
Key aspects during downstream purification of biopharmaceutical drugs are purity and process yield. Therefore, the downstream process needs to be designed in a way that the final product which will eventually end up in the patient entails low levels of product- and process related impurities (e.g. high molecular weight aggregates) as well as process related contaminants (e.g. host cell protein levels). In addition to this, the process must be capable of clearing and inactivating viruses to ensure product safety. In this webinar, we will explore the benefits of adding excipients during downstream processing on protein stability, chromatographic performance and viral inactivation.
Dark fermentative hydrogen production is an intermediate microbial process occurring along anaerobic microbial degradation of organic matter. One direct application of this fermentative bioprocess consists in the production of renewable H2 and simultaneous treatment of organic pollutants. Nowadays, high amounts of saline effluents are generated by fish, seafood, petroleum and leather industries. Such saline effluents are rarely treated by biological anaerobic processes that are strongly inhibited by high salt concentrations. Alternative biological processes, such as dark fermentation, still remain to be investigated with the aim of removing organic pollution from such saline effluents. Moreover, more knowledge about the effect of saline conditions on fermentative microbial mixed cultures would provide new insights on the bacterial inhibition resulting from their exposition to saline conditions.
This study deals with the characterization of hydrogen-producing microbial communities after increasing salt concentrations in a range compatible with a marine environment.
A series of batch experiments was performed under anaerobic conditions favorable to hydrogen production, with a NaCl concentration ranging from 9 to 75 gNaCl/L. Marine sediments were used as inoculum. Biogas and bacterial metabolites were monitored over experimental time. The bacterial community structure dynamics were characterized using molecular tools based on the analysis of genomic 16S rDNA (CE-SSCP), and individual bacterial species were further identified by pyrosequencing.
As a result, the significant and highest biohydrogen production yield (0.9±0.04 molH2.molGlucose-1) was observed at the highest NaCl concentration of 75 g.L-1. However, by increasing the NaCl concentration, the bioH2 production rates slowed down gradually, and longer lag phases were observed. A clear and gradual metabolic shift was also observed suggesting a substantial impact of the saline environment on anaerobic bacterial metabolism, as well as a high selection pressure on acidogenic bacteria. As expected, the composition of the bacterial community at 9gNaCl/L (control) was consistent with literature data, with Clostridium sp. and Enterobacter sp as main dominant species. Interestingly, a gradual shift of the bacterial community structure, concomitant to metabolic changes, was observed by increasing NaCl concentration, with Vibrio sp. as new dominant bacteria (87% in abundance) at the highest salinities. This is the first report on the presence of Vibrio sp. as main hydrogen-producing bacteria in such acidogenic mixed-cultures.
Thus, this study provides new insights on anaerobic metabolism occurring in saline conditions with new possibilities of biotechnological applications from such saline effluents.
Comprehensive Investigation of the Utilization of SFC/ESI Positive Mode MS fo...Waters Corporation
Bioanalysis and drug metabolism studies are critical parts of the drug development process. The aim of these studies is to identify and quantify drugs and their associated metabolites in biofluids such as plasma and urine. Typically reversed-phase chromatography coupled with mass spectrometry is often the analytical technique of choice utilized in the analyses due to the specificity and sensitivity of the technique. However, due to the complexity of the biofluid samples accurate and precise measurements can become challenging due to poor chromatographic peak shape, insufficient chromatographic resolution from matrix components and incompatible sample compositions.
Recent advancements in the field of super critical fluid chromatography (SFC) have lead to the development of sub 2 micron chromatographic separations coupled mass spectrometry operating under positive ESI mode. In the work presented here the applicability of SFC for both chiral and achiral bioanalysis is shown. The orthogonal separation selectivity compared with reversed-phase separations and tolerance for high organic sample compositions will be discussed. This work further presents a critical evaluation of the influence of mobile phase and make up flow modifiers on the sensitivity and selectivity of probe pharmaceuticals analyzed under SFC/ESI positive mode MS conditions.
Paul Rainville of Waters Corporation gave this Oral presentation at Pittcon 2015.
One Pot Hydrothermal Synthesis Characterizations Of Silver Nanoparticles On R...IOSRJAC
Graphene-based nanocomposite have significant applicability in catalysis, electronics, medicine, and energy. In this report silver nanoparticles (AgNPs) with Reduced Graphene Oxide (RGO) - nanocomposite was prepared by a one-pot hydrothermal process using silver nitrate as a precursor. Under hydrothermal process Graphene oxide (GO) was reduced to reduced graphene oxide (RGO), without using chemical reagents. As synthesized (Ag-RGO) nanocomposite was characterized by XRD, UV Vis-spectroscopy, Scanning electron microscope, and Raman spectroscopy. Antimicrobial activities of the composite were investigated against both Gram-positive and Gram-negative bacteria. The results demonstrate that Ag-RGO nanocomposite was a strong bactericide against Gram-negative bacteria. Antioxidant activity was evaluated for bare GO, Ag and Ag-RGO nanocomposite by DPPH radical scavenging assay. It was observed that Ag/RGO nanocomposite has enhanced antioxidant activity than bare GO and Ag.
Absolute quantification of mAbs and ADCs : forget amino acid analysis and shi...Quality Assistance s.a.
Absolute quantification of mAbs and ADCs: Quality Assistance developed an innovative analytical method based on sulfur quantification by ICP-MS/MS
Visit www.quality-assistance.com for more information
The Determination of Total Protein Using the LAMBDA UV/Vis Spectrophotometer:...PerkinElmer, Inc.
Quantification methods for total protein are among the longest-established fundamental and important experiments of bioscience. UV/Vis Spectrophotometry is widely used for the determination of protein. This application note describes a typical protein method, the Bradford method. Data is rapidly acquired using the LAMBDA™ 465 UV/Vis Spectrophotometer and processed using the UV Lab™ Software.
Practical Implementation of the New Elemental Impurities Guidelines May 2015SGS
The International Conference on Harmonization (ICH) released its Q3D Guideline for Elemental Impurities in December 2014, initiating reviews and changes in quality testing programs in bio/pharmaceutical companies around the world. In advance of the implementation dates, companies need to assess the risks of potential elemental impurities in their process and materials streams.
In this presentation, experts will review the requirements of elemental impurities guidelines from ICH, the European Pharmacopeia, and United States Pharmacopeia, outline practical recommendations to address implementation challenges, and discuss key considerations for analytical testing programs.
In this webinar, we have Dr. Stephanie Smith from Xylem introduce how to detect Harmful Algae Blooms (HABs) in the lab. Stephanie goes into details on three key methods and the equipment we provide to support the testing.
Topics Covered:
- Importance of Monitoring HABs
- Method 1: Total Phosphorus (TP) by USEPA Method 365.4
- Method 2: Total Kjeldahl Nitrogen (TKN) by USEPA Method 351.2
- Method 3: Purge and Trap with GC/MS, guided by USEPA Method 524.3 for volatile organics
View the event and watch the video here: https://www.xylem.com/en-sg/about-xylem/newsroom/events/get-your-lab-ready-for-harmful-algal-blooms-habs/
Novel Approaches to Omega-3 Stability Testing Nutrasource
In the last decade, nutritional oil products such as omega-3s have grown to a multi-billion dollar industry globally. As a result, new analytical testing challenges have arisen from the current trend toward producing more attractive and more appetizing products created for a wider consumer base.
In formulating these "new and improved," better looking and better tasting products, different color and flavor additives are used, which can interfere with the most popular analytical procedure for determining the secondary oxidation of nutritional oil products, the p-anisidine value test.
In order to overcome these analytical challenges, a new alternative method for testing these additive-laden products has been established and is ready for use in this fast growing marketing segment.
Dr. Steven Li provides details about the latest innovation in omega-3 testing and its application in the omega-3 industry, at GOED Exchange 2014.
These slide notes describe protein analysis methods. In this part of the presentation, both official and non-official methods of analyzing proteins in food samples are combined. However, Kidjeldah Method is also given. Moreover, the principles of each and every method were highly explained and illustrated.
Over the past decade, there have been a growing number of mAb candidates entering the clinical pipeline. This results in a large increase on the demand for analytical characterization. This seminar discusses advances in analytical method development with analytical run times below 10 minutes for all routine methods with intelligent, integrated chromatography workflows. Orbitrap technology has been established as the most powerful MS technology for protein characterization. How this can be incorporated into a complete workflow for bio-pharma analysis is also discussed.
It is widely known that toxic metals can be found in some foods because they are naturally present in the Earth’s crust and can be released as pollutants into the water and soil used to grow food and through the food manufacturing and packaging processes. Exposure to these metals at an early age has been linked to developmental problems, behavior issues, and attention deficit hyperactivity disorder. The levels of toxic metals in baby foods are therefore more of a concern and require strict safety controls from raw materials to finished products. In this work, we explore and discuss the applicability of the Shimadzu inductively coupled plasma-mass spectrometer (Shimadzu ICPMS-2030) to the quantification of As, Cd, Hg and Pb in selected baby foods at this very low limit ranges.
LC-MS/MS analysis of emerging food contaminantsSCIEX
Recently (November 2014), threats in the form of letters were sent to farming and dairy industry leaders in New Zealand. The letters were accompanied by small packages of milk powder that were shown to contain a concentrated form of the pesticide 1080 (sodium fluoroacetate). The sender demanded that the New Zealand government stop using 1080 for pest control. Sodium fluoroacetate is used to protect New Zealand’s native flora and fauna against introduced pests like possums and ferrets. Opponents, however, argue that it also kills native animals and contaminates the environment.1-2
Such criminal threats are a potential danger and weaken consumers’ trust in the food supply chain. Accurate and reliable analytical methods are needed to monitor food ingredients and final products to ensure food safety in light of this threat.
Liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS) is an ideal analytical technique to detect polar analytes in complex food samples.
Here we present first results of method development to detect sodium fluoroacetate in milk and infant formula. The sample preparation protocol consists of a simple acetonitrile extraction and defatting using hexane. LC separation was achieved using a HILIC column in normal phase mode. The mass spectrometer was operated in Multiple Reaction Monitoring (MRM) mode. In MRM mode the transition of a molecular ion into a characteristic fragment ion is monitored. The monitoring of more than a single fragment ion allows not only quantitation but also highly confident identification based on the ratio between quantifier and qualifier transitions.
Initial studies show that sodium fluoroacetate can be detected at concentrations below 1 ng/mL (below 10 ng/mL in matrix) using the SCIEX QTRAP® 4500 system, with good accuracy and repeatability. Linearity for quantitation was achieved over 3 orders of magnitude (0.1 to 100 ng/mL). Future experiments are planned to further increase sensitivity, simplify sample preparation and to include an internal standard to correct low recoveries and matrix effects.
Comprehensive Investigation of the Utilization of SFC/ESI Positive Mode MS fo...Waters Corporation
Bioanalysis and drug metabolism studies are critical parts of the drug development process. The aim of these studies is to identify and quantify drugs and their associated metabolites in biofluids such as plasma and urine. Typically reversed-phase chromatography coupled with mass spectrometry is often the analytical technique of choice utilized in the analyses due to the specificity and sensitivity of the technique. However, due to the complexity of the biofluid samples accurate and precise measurements can become challenging due to poor chromatographic peak shape, insufficient chromatographic resolution from matrix components and incompatible sample compositions.
Recent advancements in the field of super critical fluid chromatography (SFC) have lead to the development of sub 2 micron chromatographic separations coupled mass spectrometry operating under positive ESI mode. In the work presented here the applicability of SFC for both chiral and achiral bioanalysis is shown. The orthogonal separation selectivity compared with reversed-phase separations and tolerance for high organic sample compositions will be discussed. This work further presents a critical evaluation of the influence of mobile phase and make up flow modifiers on the sensitivity and selectivity of probe pharmaceuticals analyzed under SFC/ESI positive mode MS conditions.
Paul Rainville of Waters Corporation gave this Oral presentation at Pittcon 2015.
One Pot Hydrothermal Synthesis Characterizations Of Silver Nanoparticles On R...IOSRJAC
Graphene-based nanocomposite have significant applicability in catalysis, electronics, medicine, and energy. In this report silver nanoparticles (AgNPs) with Reduced Graphene Oxide (RGO) - nanocomposite was prepared by a one-pot hydrothermal process using silver nitrate as a precursor. Under hydrothermal process Graphene oxide (GO) was reduced to reduced graphene oxide (RGO), without using chemical reagents. As synthesized (Ag-RGO) nanocomposite was characterized by XRD, UV Vis-spectroscopy, Scanning electron microscope, and Raman spectroscopy. Antimicrobial activities of the composite were investigated against both Gram-positive and Gram-negative bacteria. The results demonstrate that Ag-RGO nanocomposite was a strong bactericide against Gram-negative bacteria. Antioxidant activity was evaluated for bare GO, Ag and Ag-RGO nanocomposite by DPPH radical scavenging assay. It was observed that Ag/RGO nanocomposite has enhanced antioxidant activity than bare GO and Ag.
Absolute quantification of mAbs and ADCs : forget amino acid analysis and shi...Quality Assistance s.a.
Absolute quantification of mAbs and ADCs: Quality Assistance developed an innovative analytical method based on sulfur quantification by ICP-MS/MS
Visit www.quality-assistance.com for more information
The Determination of Total Protein Using the LAMBDA UV/Vis Spectrophotometer:...PerkinElmer, Inc.
Quantification methods for total protein are among the longest-established fundamental and important experiments of bioscience. UV/Vis Spectrophotometry is widely used for the determination of protein. This application note describes a typical protein method, the Bradford method. Data is rapidly acquired using the LAMBDA™ 465 UV/Vis Spectrophotometer and processed using the UV Lab™ Software.
Practical Implementation of the New Elemental Impurities Guidelines May 2015SGS
The International Conference on Harmonization (ICH) released its Q3D Guideline for Elemental Impurities in December 2014, initiating reviews and changes in quality testing programs in bio/pharmaceutical companies around the world. In advance of the implementation dates, companies need to assess the risks of potential elemental impurities in their process and materials streams.
In this presentation, experts will review the requirements of elemental impurities guidelines from ICH, the European Pharmacopeia, and United States Pharmacopeia, outline practical recommendations to address implementation challenges, and discuss key considerations for analytical testing programs.
In this webinar, we have Dr. Stephanie Smith from Xylem introduce how to detect Harmful Algae Blooms (HABs) in the lab. Stephanie goes into details on three key methods and the equipment we provide to support the testing.
Topics Covered:
- Importance of Monitoring HABs
- Method 1: Total Phosphorus (TP) by USEPA Method 365.4
- Method 2: Total Kjeldahl Nitrogen (TKN) by USEPA Method 351.2
- Method 3: Purge and Trap with GC/MS, guided by USEPA Method 524.3 for volatile organics
View the event and watch the video here: https://www.xylem.com/en-sg/about-xylem/newsroom/events/get-your-lab-ready-for-harmful-algal-blooms-habs/
Novel Approaches to Omega-3 Stability Testing Nutrasource
In the last decade, nutritional oil products such as omega-3s have grown to a multi-billion dollar industry globally. As a result, new analytical testing challenges have arisen from the current trend toward producing more attractive and more appetizing products created for a wider consumer base.
In formulating these "new and improved," better looking and better tasting products, different color and flavor additives are used, which can interfere with the most popular analytical procedure for determining the secondary oxidation of nutritional oil products, the p-anisidine value test.
In order to overcome these analytical challenges, a new alternative method for testing these additive-laden products has been established and is ready for use in this fast growing marketing segment.
Dr. Steven Li provides details about the latest innovation in omega-3 testing and its application in the omega-3 industry, at GOED Exchange 2014.
These slide notes describe protein analysis methods. In this part of the presentation, both official and non-official methods of analyzing proteins in food samples are combined. However, Kidjeldah Method is also given. Moreover, the principles of each and every method were highly explained and illustrated.
Over the past decade, there have been a growing number of mAb candidates entering the clinical pipeline. This results in a large increase on the demand for analytical characterization. This seminar discusses advances in analytical method development with analytical run times below 10 minutes for all routine methods with intelligent, integrated chromatography workflows. Orbitrap technology has been established as the most powerful MS technology for protein characterization. How this can be incorporated into a complete workflow for bio-pharma analysis is also discussed.
It is widely known that toxic metals can be found in some foods because they are naturally present in the Earth’s crust and can be released as pollutants into the water and soil used to grow food and through the food manufacturing and packaging processes. Exposure to these metals at an early age has been linked to developmental problems, behavior issues, and attention deficit hyperactivity disorder. The levels of toxic metals in baby foods are therefore more of a concern and require strict safety controls from raw materials to finished products. In this work, we explore and discuss the applicability of the Shimadzu inductively coupled plasma-mass spectrometer (Shimadzu ICPMS-2030) to the quantification of As, Cd, Hg and Pb in selected baby foods at this very low limit ranges.
LC-MS/MS analysis of emerging food contaminantsSCIEX
Recently (November 2014), threats in the form of letters were sent to farming and dairy industry leaders in New Zealand. The letters were accompanied by small packages of milk powder that were shown to contain a concentrated form of the pesticide 1080 (sodium fluoroacetate). The sender demanded that the New Zealand government stop using 1080 for pest control. Sodium fluoroacetate is used to protect New Zealand’s native flora and fauna against introduced pests like possums and ferrets. Opponents, however, argue that it also kills native animals and contaminates the environment.1-2
Such criminal threats are a potential danger and weaken consumers’ trust in the food supply chain. Accurate and reliable analytical methods are needed to monitor food ingredients and final products to ensure food safety in light of this threat.
Liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS) is an ideal analytical technique to detect polar analytes in complex food samples.
Here we present first results of method development to detect sodium fluoroacetate in milk and infant formula. The sample preparation protocol consists of a simple acetonitrile extraction and defatting using hexane. LC separation was achieved using a HILIC column in normal phase mode. The mass spectrometer was operated in Multiple Reaction Monitoring (MRM) mode. In MRM mode the transition of a molecular ion into a characteristic fragment ion is monitored. The monitoring of more than a single fragment ion allows not only quantitation but also highly confident identification based on the ratio between quantifier and qualifier transitions.
Initial studies show that sodium fluoroacetate can be detected at concentrations below 1 ng/mL (below 10 ng/mL in matrix) using the SCIEX QTRAP® 4500 system, with good accuracy and repeatability. Linearity for quantitation was achieved over 3 orders of magnitude (0.1 to 100 ng/mL). Future experiments are planned to further increase sensitivity, simplify sample preparation and to include an internal standard to correct low recoveries and matrix effects.
Enzyme Based Analytical Chemistry - Nitrate and the U.S. EPAAnna-Marie Davidson
Learn about how a recombinant enzyme, nitrate reductase, is used for analytical quantification of nitrate in a variety of complex sample matrices. Check out data from the U.S. EPA CWA validation study and all of the various formats NECi Superior Enzymes offers from laboratory to on-site. Be in the know of recent research regarding recombinant protein technology for analytical chemistry.
Tout ce que vous voulez savoir sur la vaccination COVID-19 (9 février 2021)Quality Assistance s.a.
Nous avons eu l'honneur et le plaisir d'accueillir le Professeur Jean-Michel Dogné, expert au Comité Mondial de Sécurité Vaccinale de l’OMS, à l'occasion d'un Webinar informatif sur le thème de la “Vaccination COVID-19”.
PROGRAMME:
Différentes phases de la contamination à la COVID-19
Quels sont les objectifs de la vaccination ?
Comment le corps fait-il pour développer une immunité ?
Comment le vaccin a-t-il été développé aussi vite ?
La répartition des doses des différents vaccins
Dans quelles circonstances le vaccin sera-t-il efficace ?
Efficacité du vaccin
Composition de l’injection
Qui doit se faire vacciner et pourquoi ?
Potentiels risques du vaccin sur le long terme
Explications sur la politique de transparence via la plateforme AFMPS
A PROPOS DU PROFESSEUR JEAN-MICHEL DOGNÉ:
Fort d’une expertise de 14 ans dans le domaine de la sécurité des médicaments et des vaccins auprès des agences belge (AFMPS) et européenne (EMA) des Médicaments, Jean-Michel Dogné a été nommé début 2020 en tant qu’expert au Comité Mondial de Sécurité Vaccinale de l’Organisation Mondiale de la Santé. Directeur du Département de pharmacie de l’Université de Namur et membre de l’Institut de recherche Narilis, il compte plus de 200 publications en pharmacochimie, pharmacologie, pharmacovigilance et en sécurité du médicament.
PLUS D'INFORMATIONS:
https://www.quality-assistance.com/events/tout-ce-que-vous-voulez-savoir-sur-la-vaccination-covid-19
Multiple Heartcut 2D-LC/MS: a powerful tool for biopharma analysis in a regul...Quality Assistance s.a.
Multiple Heartcut 2D-LC/MS: a powerful tool for biopharma analysis in a regulated environment (WEBAF, Dublin 2019)
Visit www.quality-assistance.com for more information
Structural characterisation and epitope mapping by HDX-MS (Advanced Analytica...Quality Assistance s.a.
Hydrogen-Deuterium Exchange Mass Spectrometry (HDX-MS) is an innovative tool for the characterisation of biotherapeutics. Besides the study of higher-order structures, HDX-MS can also be used for epitope mapping studies in order to determine to which region of the target a monoclonal antibody binds. HDX-MS is a good alternative to techniques such as X-ray diffraction or NMR.
Visit www.quality-assistance.com for more information
Arnaud DELOBEL, R&D Director, Quality Assistance
Webinar held on 2nd April 2019.
Hydrogen-Deuterium Exchange Mass Spectrometry (HDX-MS) is a powerful technique for the advanced structural characterisation of proteins and the study of protein-protein interactions.This technique has been used for several decades, mostly in academic labs. Thanks to advances in automation, liquid chromatography and mass spectrometry technologies, this technique can now be used to get reproducible and reliable results in characterisation studies of biotherapeutics. It is complementary to other structural biology techniques such as NMR and X-ray cristallography. Its main advantage is to work in nearly physiological conditions and to require relatively limited amounts of sample.
Access this 45 minutes webinar to learn how HDX-MS can be applied throughout the development of your product to get structural information that can hardly be obtained with other techniques. After a detailed description of the technique and its applications, case studies will be presented in the context of comparability and epitope mapping studies.
Visit www.quality-assistance.com for more information.
Stratégies orthogonales pour la caractérisation de glycoprotéines thérapeutiq...Quality Assistance s.a.
Stratégies orthogonales pour la caractérisation de glycoprotéines thérapeutiques par LC/MS par Arnaud Delobel, R&D Director
Visit www.quality-assistance.com for more information
Nouveaux outils pour la caractérisation et l'analyse structurale des mAbs et ...Quality Assistance s.a.
Depuis la fin de la phase de screening jusqu’à l’enregistrement du médicament, au travers des phases non-cliniques et cliniques, Quality Assistance met au point des solutions personnalisées: nous définissons les protocoles analytiques, développons des méthodes d’analyse spécifiques et/ou réalisons les études de caractérisation, de stabilité, de pharmacocinétique, les tests de biomarqueurs et d’immunogénicité ainsi que le contrôle des lots permettant d’évaluer l’innocuité, l’efficacité et la qualité des produits confiés.
Nous occupons une position unique sur le marché grâce à :
- la centralisation de tous nos laboratoires sur un seul site
- 180 professionnels hautement qualifiés
- plus de 35 ans d'expérience en sciences analytiques
Dr Arnaud Delobel, R&D Director, a présenté les nouveaux outils pour la caractérisation et l'analyse structurale des mAbs et ADCS : MS native, 2D-LC/MS et HDX, au Forum Pharma et Biopharma 2019 (Waters).
5 Février 2019, à Paris, France
Visitez www.quality-assistance.com pour plus d'informations
Analytical methods: key considerations to efficiently bring ADCs to the marketQuality Assistance s.a.
Quality Assistance adds value to your ADCs development. Thanks to our combined experience with small molecule cytotoxics and monoclonal antibodies, we can provide full analytical support for your projects. We offer a wide range of services for all payload categories (maytansine derivatives, auristatins, etc.) and all conjugation strategies (lysine, cysteine, site-specific).
Quality Assistance has become a leader in analytical sciences and holds a unique position on the market with all its laboratories on one site and 170 highly qualified professionals.
Dr Arnaud Delobel, R&D Director, presented on the analytical methods and key considerations to efficiently bring ADCs to the market, at World ADC conference (27 March 2018, in Berlin, Germany).
Visit www.quality-assistance.com for more information
WEBINAR Characterisation of human pluripotent stem cells (ESCs and IPSC) and ...Quality Assistance s.a.
Valérie DEFFONTAINE, R&D Scientist, Quality Assistance
Webinar held on 8th June 2017.
The discovery of human pluripotent stem cells 10 years ago turned the spotlight on the potential of pluripotent stem cells for personalised cell therapy. The scientific interest then quickly shifted towards the use of these cells for safety pharmacology, drug discovery and disease modelling. For all these purposes, in the mid to long term, properly characterised cell banks will be necessary.
The characterisation of embryonic (ESC) and induced pluripotent stem cells (IPSC) used for manufacturing requires the development and validation of analytical methods (e.g. flow cytometry, microscopy, QPCR and bioassays). Cell characterisation includes the testing of cell product identity, determination of impurities, and assessment of biological activity and viability. Among the techniques available, flow cytometry is widely used to assess the expression of cell markers. Our laboratory has developed flow cytometry panels dedicated to the characterisation of extracellular and intracellular markers of ESC and IPSC, and to the detection of cell-related impurities. We proposed a method for the validation of flow cytometry panels according to the recommendations of international guidelines on the validation of analytical methods.
IPSC differentiated into cardiomyocytes and MSC-like cells were also used to test the performance of our flow cytometry panels to accurately monitor the manufacturing process of cell products.
In addition to the technical tips, this webinar aims at presenting a critical view on the use of flow cytometry platform for cell characterisation.
For more information, visit http://www.quality-assistance.com/analytical-services/CBMPs
Development of quality control assays for cell-based medicinal products (ISCT...Quality Assistance s.a.
Dr. Fabian Vandermeers from Quality Assistance spoke on Development of quality control assays for cell-based medicinal products at ISCT 2017 in London.
For more information on this topic, visit: http://www.quality-assistance.com/analytical-services/CBMPs
For more information on our expertise and services, visit: www.quality-assistance.com
Follow us on social media:
LinkedIn: https://www.linkedin.com/company/quality-assistance
Twitter: https://twitter.com/QA_Belgium
Facebook: https://www.facebook.com/QualityAssistanceBelgium
Google +: https://plus.google.com/103676189647965359292
Quality Assistance S.A. is a leading European Contract Research Organisation providing the pharmaceutical industry with all the analytical services required by EMA and FDA regulations for the development and marketing of innovative human medicinal products.
We assist our clients from candidate selection, through non-clinical and clinical studies, to marketing authorisation, using our state-of-the-art, product-dedicated expertise in analytical sciences.
For each customer and each project, we design customised solutions, define analytical protocols, develop and validate specific new analytical methods and perform characterisation, stability, pharmacokinetic, biomarker and immunogenicity studies as well as batch release testing, in order to evaluate the Quality, Safety and Efficacy of the given drugs.
Advances in LC/MS methodologies for the characterisation of complex glycoprot...Quality Assistance s.a.
Dr. Arnaud Delobel from Quality Assistance spoke on "Advances in LC/MS methodologies for the characterisation of complex glycoproteins (case study: Etanercept)" at the "Challenges and Opportunities in Protein Analytics" day in Brussels.
For more information on our expertise and services, visit: www.quality-assistance.com
Follow us on social media:
LinkedIn: https://www.linkedin.com/company/quality-assistance
Twitter: https://twitter.com/QA_Belgium
Facebook: https://www.facebook.com/QualityAssistanceBelgium
Google +: https://plus.google.com/103676189647965359292
Quality Assistance S.A. is a leading European Contract Research Organisation providing the pharmaceutical industry with all the analytical services required by EMA and FDA regulations for the development and marketing of innovative human medicinal products.
We assist our clients from candidate selection, through non-clinical and clinical studies, to marketing authorisation, using our state-of-the-art, product-dedicated expertise in analytical sciences.
For each customer and each project, we design customised solutions, define analytical protocols, develop and validate specific new analytical methods and perform characterisation, stability, pharmacokinetic, biomarker and immunogenicity studies as well as batch release testing, in order to evaluate the Quality, Safety and Efficacy of the given drugs.
Advances in Mass Spectrometry for the Characterisation and Bioanalysis of ADC...Quality Assistance s.a.
Dr. Arnaud Delobel from Quality Assistance spoke on advances in Mass Spectrometry for the Characterisation & Bioanalysis of ADCs at World ADC 2017 in Berlin.
For more on this topic, replay the full ADCs webinar here: http://bit.ly/2kW3KoN
With a full analytical package for Biologics, Quality Assistance provides scientific and technical support to biopharmaceutical companies developing Antibody-Drug Conjugates.
Specificaly, we can develop and/or optimise the analytical methods for a product and, if necessary, validate them according to international guidelines for batch release, stability testing and/or regulated bioanalysis.
For more information on our expertise and services, visit: www.quality-assistance.com
Follow us on social media:
LinkedIn: https://www.linkedin.com/company/quality-assistance
Twitter: https://twitter.com/QA_Belgium
Facebook: https://www.facebook.com/QualityAssistanceBelgium
Google +: https://plus.google.com/103676189647965359292
Quality Assistance S.A. is a leading European Contract Research Organisation providing the pharmaceutical industry with all the analytical services required by EMA and FDA regulations for the development and marketing of innovative human medicinal products.
We assist our clients from candidate selection, through non-clinical and clinical studies, to marketing authorisation, using our state-of-the-art, product-dedicated expertise in analytical sciences.
For each customer and each project, we design customised solutions, define analytical protocols, develop and validate specific new analytical methods and perform characterisation, stability, pharmacokinetic, biomarker and immunogenicity studies as well as batch release testing, in order to evaluate the Quality, Safety and Efficacy of the given drugs.
Q3D - Elemental Impurities: What implications for APIs & excipients suppliers?Quality Assistance s.a.
ICH Q3D Step4 will have to be applied very soon: June 2016 for new Drug Products and
1st January 2018 for all existing DP, making it mandatory for all manufacturers to carry out a risk assessment to control elemental impurities in their DP.
Such evaluation needs to consider all potential sources of Elemental Impurities and obviously, drug product components are probably the most likely contributors.
by Dr Ph. De Raeve, Scientific Director
For more informations : www.quality-assistance.com
Stress testing and physico-chemical characterization of monoclonal antibodies...Quality Assistance s.a.
Accelerated stress studies of biotech products can be carried out to study the main degradation pathways of the recombinant proteins to evaluate their stability, or to identify the different peaks / entities observed while running stability indicating separative methods such as ion exchange or size exclusion chromatography.
by Dr Géry Van Vyncht, R&D Director
For more informations : www.quality-assistance.com
Lors de cette conférence, les différentes catégories d’impuretés potentiellement présentes dans une substance active d’origine biotechnologique ont été étudiées. Pour chacune d’entre elles, une évaluation de la criticité en termes de sécurité et d’efficacité, une ou plusieurs solutions analytiques et une stratégie de contrôle adaptée ont été présentées. Les anticorps monoclonaux ont été utilisés comme exemple mais les recommandations se voudront extrapolables à d’autres types de protéines recombinantes. Les différents sujets ont été abordés par des experts en ces matières.
Pour plus d'information : www.quality-assistance.com
INFECTION OF THE BRAIN -ENCEPHALITIS ( PPT)blessyjannu21
Neurological system includes brain and spinal cord. It plays an important role in functioning of our body. Encephalitis is the inflammation of the brain. Causes include viral infections, infections from insect bites or an autoimmune reaction that affects the brain. It can be life-threatening or cause long-term complications. Treatment varies, but most people require hospitalization so they can receive intensive treatment, including life support.
Cold Sores: Causes, Treatments, and Prevention Strategies | The Lifesciences ...The Lifesciences Magazine
Cold Sores, medically known as herpes labialis, are caused by the herpes simplex virus (HSV). HSV-1 is primarily responsible for cold sores, although HSV-2 can also contribute in some cases.
Empowering ACOs: Leveraging Quality Management Tools for MIPS and BeyondHealth Catalyst
Join us as we delve into the crucial realm of quality reporting for MSSP (Medicare Shared Savings Program) Accountable Care Organizations (ACOs).
In this session, we will explore how a robust quality management solution can empower your organization to meet regulatory requirements and improve processes for MIPS reporting and internal quality programs. Learn how our MeasureAble application enables compliance and fosters continuous improvement.
International Cancer Survivors Day is celebrated during June, placing the spotlight not only on cancer survivors, but also their caregivers.
CANSA has compiled a list of tips and guidelines of support:
https://cansa.org.za/who-cares-for-cancer-patients-caregivers/
Dr. David Greene R3 stem cell Breakthroughs: Stem Cell Therapy in CardiologyR3 Stem Cell
Dr. David Greene, founder and CEO of R3 Stem Cell, is at the forefront of groundbreaking research in the field of cardiology, focusing on the transformative potential of stem cell therapy. His latest work emphasizes innovative approaches to treating heart disease, aiming to repair damaged heart tissue and improve heart function through the use of advanced stem cell techniques. This research promises not only to enhance the quality of life for patients with chronic heart conditions but also to pave the way for new, more effective treatments. Dr. Greene's work is notable for its focus on safety, efficacy, and the potential to significantly reduce the need for invasive surgeries and long-term medication, positioning stem cell therapy as a key player in the future of cardiac care.
Trauma Outpatient Center is a comprehensive facility dedicated to addressing mental health challenges and providing medication-assisted treatment. We offer a diverse range of services aimed at assisting individuals in overcoming addiction, mental health disorders, and related obstacles. Our team consists of seasoned professionals who are both experienced and compassionate, committed to delivering the highest standard of care to our clients. By utilizing evidence-based treatment methods, we strive to help our clients achieve their goals and lead healthier, more fulfilling lives.
Our mission is to provide a safe and supportive environment where our clients can receive the highest quality of care. We are dedicated to assisting our clients in reaching their objectives and improving their overall well-being. We prioritize our clients' needs and individualize treatment plans to ensure they receive tailored care. Our approach is rooted in evidence-based practices proven effective in treating addiction and mental health disorders.
The dimensions of healthcare quality refer to various attributes or aspects that define the standard of healthcare services. These dimensions are used to evaluate, measure, and improve the quality of care provided to patients. A comprehensive understanding of these dimensions ensures that healthcare systems can address various aspects of patient care effectively and holistically. Dimensions of Healthcare Quality and Performance of care include the following; Appropriateness, Availability, Competence, Continuity, Effectiveness, Efficiency, Efficacy, Prevention, Respect and Care, Safety as well as Timeliness.
Rate Controlled Drug Delivery Systems, Activation Modulated Drug Delivery Systems, Mechanically activated, pH activated, Enzyme activated, Osmotic activated Drug Delivery Systems, Feedback regulated Drug Delivery Systems systems are discussed here.
KEY Points of Leicester travel clinic In London doc.docxNX Healthcare
In order to protect visitors' safety and wellbeing, Travel Clinic Leicester offers a wide range of travel-related health treatments, including individualized counseling and vaccines. Our team of medical experts specializes in getting people ready for international travel, with a particular emphasis on vaccines and health consultations to prevent travel-related illnesses. We provide a range of travel-related services, such as health concerns unique to a trip, prevention of malaria, and travel-related medical supplies. Our clinic is dedicated to providing top-notch care, keeping abreast of the most recent recommendations for vaccinations and travel health precautions. The goal of Travel Clinic Leicester is to keep you safe and well-rested no matter what kind of travel you choose—business, pleasure, or adventure.
Feeding plate for a newborn with Cleft Palate.pptxSatvikaPrasad
A feeding plate is a prosthetic device used for newborns with a cleft palate to assist in feeding and improve nutrition intake. From a prosthodontic perspective, this plate acts as a barrier between the oral and nasal cavities, facilitating effective sucking and swallowing by providing a more normal anatomical structure. It helps to prevent milk from entering the nasal passage, thereby reducing the risk of aspiration and enhancing the infant's ability to feed efficiently. The feeding plate also aids in the development of the oral muscles and can contribute to better growth and weight gain. Its custom fabrication and proper fitting by a prosthodontist are crucial for ensuring comfort and functionality, as well as for minimizing potential complications. Early intervention with a feeding plate can significantly improve the quality of life for both the infant and the parents.
Stem Cell Solutions: Dr. David Greene's Path to Non-Surgical Cardiac CareDr. David Greene Arizona
Explore the groundbreaking work of Dr. David Greene, a pioneer in regenerative medicine, who is revolutionizing the field of cardiology through stem cell therapy in Arizona. This ppt delves into how Dr. Greene's innovative approach is providing non-surgical, effective treatments for heart disease, using the body's own cells to repair heart damage and improve patient outcomes. Learn about the science behind stem cell therapy, its benefits over traditional cardiac surgeries, and the promising future it holds for modern medicine. Join us as we uncover how Dr. Greene's commitment to stem cell research and therapy is setting new standards in healthcare and offering new hope to cardiac patients.
Tips for Pet Care in winters How to take care of pets.
WEBINAR: Absolute quantification of mAbs and ADCs: forget amino acid analysis and shift to the new gold standard
1. 1Arnaud Delobel, PhD – Webinar Quality Assistance – May 23rd 2019
Absolute quantification of
mAbs and ADCs: forget
amino acid analysis and
shift to the new gold
standard
Arnaud Delobel, PhD
Director, R&D
2. 2Arnaud Delobel, PhD – Webinar Quality Assistance – May 23rd 2019
Agenda
• Presentation of Quality Assistance
• Absolute quantification: why and how?
• Development of an ICP/MS method for protein quantification
• Method validation
• How to apply the method to ADCs?
3. 3Arnaud Delobel, PhD – Webinar Quality Assistance – May 23rd 2019
Quality Assistance sa
100% analytical services
100% (bio)pharmaceutical industry
189 highly-qualified employees
> 60% university graduates
77 worldwide R&D companies
& 200 projects (2018)
Product dedicated support
Customised project management
Compliance with EMA / FDA regulations
From discovery to market place
All laboratories on one site
5700 m²
9600 hours
5 clients
8 projects
ADC expertise
(2018)
+35 years experience
~1.1 M € in machinery
& equipment (2018)
22200 hours
16 clients
35 projects
mAbs expertise
(2018)
4. 4Arnaud Delobel, PhD – Webinar Quality Assistance – May 23rd 2019
• Quantity of the active substance in a drug product is a critical
quality attribute, directly linked to the efficacy and safety of the drug
• A precise and accurate method is required to evaluate batch-to-
batch consistency
• Determination of protein concentration is a prerequisite to measure
the extinction coefficient ε of a protein
▪ ε is used as part of the fine characterisation of a protein
▪ ε is used for comparability or biosimilarity studies
Quantification of proteins: why?
5. 5Arnaud Delobel, PhD – Webinar Quality Assistance – May 23rd 2019
• Absolute vs relative quantification: What does absolute mean ?
▪ Quantification without the reference substance
▪ No need for a well characterised standard of the protein to be quantified!
• Usual « absolute » methods
▪ Colorimetric (Lowry, Bradford, BCA, …)
• Usually with BSA as standard: large variability, important bias (up to 50 %)
▪ Amino Acid Analysis
▪ UV spectroscopy: requires knowledge of the molar extinction coefficient, in other
words prior availability of the reference protein
• Classical relative methods
▪ ELISA, LC-MS, LC-UV, …
▪ All require calibration with a standard solution of the protein to be assayed. Such a
standard is not readily available in most cases
Quantification of proteins: how?
7. 7Arnaud Delobel, PhD – Webinar Quality Assistance – May 23rd 2019
Inductively-Coupled Plasma / Mass Spectrometry
ICP/MS
8. 8Arnaud Delobel, PhD – Webinar Quality Assistance – May 23rd 2019
• Metallo-proteins
▪ ICP-MS obvious for a protein containing a metallic hetero-element with a
known stoechiometry.
• Fe for Hemoglobin
• Se for a Seleno-protein
▪ But applicable for a few proteins only !
• Common proteins
▪ Most proteins (> 95 %) contain Sulphur (Methionine and Cysteine residues)
▪ If elemental composition known:
Sulphur determination = protein quantification
▪ e.g. BSA : C2932H4614N780O898S39 : 1.883 % (w/w) S
Why ICP/MS for protein analysis?
9. 9Arnaud Delobel, PhD – Webinar Quality Assistance – May 23rd 2019
• High ionization potential (10.4 eV) → low sensitivity
• For 32S+, 34S+, 32SO+, 34SO+ : many polyatomic interferences
Sulphur determination by ICP/MS: a challenge!
10. 10Arnaud Delobel, PhD – Webinar Quality Assistance – May 23rd 2019
Sulphur determination by ICP/MS
• New instrument technology available: ICP-QQQ
(Agilent 8800/8900 Triple Quadrupole)
• Allows operation in MRM-like mode
• Elimination of virtually all interferences
• High sensitivity
• LOQ governed by residual sulphur in reagents and solvents
11. 11Arnaud Delobel, PhD – Webinar Quality Assistance – May 23rd 2019
• Sample preparation: digestion is needed
• High sensitivity requires low contamination
• Sulphur contained in the formulation must be taken into account
• To increase accuracy and precision: isotope dilution with 34SO4
(IDMS)
Method development
Undigested sample solutions Sulphur recovery
1 ppm S as H2SO4 100 %
1 ppm S as Methionine > 95 %
1 ppm S as BSA < 90 %
12. 12Arnaud Delobel, PhD – Webinar Quality Assistance – May 23rd 2019
Quantification using Isotope Dilution
13. 13Arnaud Delobel, PhD – Webinar Quality Assistance – May 23rd 2019
Quantification using Isotope Dilution
14. 14Arnaud Delobel, PhD – Webinar Quality Assistance – May 23rd 2019
Quantification using Isotope Dilution
15. 15Arnaud Delobel, PhD – Webinar Quality Assistance – May 23rd 2019
• Isotope ratio: Q1 & Q2 are set alternatively to 32/48 or 34/50 to measure 32S or
34S
• Double IDMS
▪ Black marbles = 34SO4 solution added to samples
▪ 34SO4 spiking solution is prepared by oxidation of 34S Sulfur: its exact concentration is not
accurately known.
▪ Concentration of the 34SO4 solution is determined by reverse IDMS with a certified solution of
SO4 (natural Sulfur isotopic abundance), NIST traceable.
▪ Reverse isotope dilution allows also to compensate for sentivity differences observed in
ICP-MS between 32S and 34S (mass discrimination)
Quantification using Isotope Dilution
16. 16Arnaud Delobel, PhD – Webinar Quality Assistance – May 23rd 2019
Workflow of the method
34S
Oxidation
(HNO3 / H2O2, 30’)
Standard stock
solution
Addition of sulphur
ICP standard
17. 17Arnaud Delobel, PhD – Webinar Quality Assistance – May 23rd 2019
Workflow of the method
34S
Mineralisation
(HNO3 / H2O2, 30’)
Standard stock
solution
Addition of sulphur
ICP standard
18. 18Arnaud Delobel, PhD – Webinar Quality Assistance – May 23rd 2019
Workflow of the method
Standard stock
solution
Sample solution
(50 µg S in 1-5 mL)
3 kDa MWCO-filtered
sample solution
Mineralisation
(HNO3 / H2O2 / HCl, 30’)
ICP-MS/MS analysis
Sulphur (32S/34S) quantification by IDMS
Absolute protein
quantification
19. 19Arnaud Delobel, PhD – Webinar Quality Assistance – May 23rd 2019
ICP-MS parameters
• RF power: 1550 W
• Ar carrier gas: 0.25 L/min
• Dilution gas (Ar): 0.85 L/min
• O2 in reaction cell: 0.35 ml/min
• First quadrupole at m/z = 32 (or 34 for 34S)
• Last quadrupole at m/z = 48 (or 50 for 34SO+)
Total: 1.1 L/min
20. 20Arnaud Delobel, PhD – Webinar Quality Assistance – May 23rd 2019
• According to ICH Q2(R1) guideline
(Validation of analytical procedures – Text and methodology)
• Model compound: BSA (Bovine Serum Albumin)
NIST certified solution: 67.38 1.38 g/L ( 2.0 %)
• Additional compounds tested
▪ Trastuzumab solution (label concentration: 21 mg/mL)
▪ Human IgG (Immunoglobulins mixture from Ph. Eur.)
▪ USP BSA for Protein Quantitation RS (2.00 mg/mL)
Method validation
22. 22Arnaud Delobel, PhD – Webinar Quality Assistance – May 23rd 2019
Method validation - Precision
(repeatability and intermediate precision)
• Two different analysts carried out independently 6 determinations of
the same solution of BSA and human IgG .
• Samples
▪ BSA: NIST, SRM 927e: 67.38 mg/mL
▪ IgG: human immunoglobulin BRP batch 1
• Ph. Eur. Reference standard for molecular size: unknown content
Sample Analyst 1 Analyst 2 Total RSD (%)
Average % RSD (n = 6) Average % RSD (n = 6) n = 12
NIST BSA (mg/mL) 67.28 0.41 67.50 0.52 0.6
IgG (mg S/g) 8.39 0.13 8.33 0.19 0.7
23. 23Arnaud Delobel, PhD – Webinar Quality Assistance – May 23rd 2019
• Evaluation of matrix effect
▪ Same amount of BSA spiked with different formulation ingredients
Method validation – Matrix effect
Matrix Mean recovery (%) % RSD (n = 3)
0.9 % NaCl 100.27 0.05
PBS 100.24 0.36
10 % Sucrose 100.16 0.61
0.1 % PS-80 100.26 0.57
15 mg/mL Glycine 99.61 0.37
15 mg/mL Histidine 100.76 0.23
Worst case 100.33 0.21
24. 24Arnaud Delobel, PhD – Webinar Quality Assistance – May 23rd 2019
• Quantification in the presence of non-proteinaceous sulphur:
▪ Source of non-protein sulphur: Sulphate
▪ A BSA solution is spiked with SO4 ( 5 % of BSA Sulphur)
▪ Part of this solution is filtered through 3 kDa
• Corrected BSA recovery in spiked solution: 99.6 %
Method validation – Matrix effect
Sample Sulphur (µg/g)
A: unspiked BSA solution 36.50
B: spiked BSA solution 38.81
C: filtered solution 2.44
B-C 36.37
25. 25Arnaud Delobel, PhD – Webinar Quality Assistance – May 23rd 2019
Method validation – Matrix effect
• Quantification in the presence of non-proteinaceous sulphur:
▪ Non-protein sulphur: Methionine
▪ Methionine was added to BSA and IgG solution
▪ Solutions were filtered and Methionine recovery measured in filtrate
25
BSA sol IgG sol
Methionine added (mM) 2.05 2.05
Methionine in filtrate (mM) 2.03 2.04
% recovery 99.1 99.5
26. 26Arnaud Delobel, PhD – Webinar Quality Assistance – May 23rd 2019
Method validation - Stability of solutions
• Stability of standard, sample and blank solutions were studied after
digestion and dilution
• Storage in metal-free polypropylene tubes
• 34S/32S ratios measured on different days:
no change > 1 % in 7 days
→ All solutions are stable for at least 7 days
27. 27Arnaud Delobel, PhD – Webinar Quality Assistance – May 23rd 2019
Method validation – Impact of sample dilution
• What if we have a sample with low protein concentration?
→ Need for a large volume of sample to get 50 µg of S
→ Dilution of acids used for digestion
→ Will the digestion be complete?
• Test:
▪ Constant amount of BSA solution (40 mg) and of 34SO4
▪ Constant volumes of digestion reagents
(2 mL HNO3, 0.5 mL HCl, 1 mL H2O2)
▪ Variable volumes of water added before digestion (1 to 5 mL)
29. 29Arnaud Delobel, PhD – Webinar Quality Assistance – May 23rd 2019
Study on Trastuzumab and USP BSA
Trastuzumab solution
• Expected concentration: 21 mg/mL
• Unknown formulation
• Non proteinaceous Sulphur: 1.7 ppb ( 0.2 % of Trastuzumab Sulphur)
• Found: 20.53 mg/g (RSD = 0.02 %, n = 3)
• Recovery: 97.8 % (vs. the nominal concentration)
• Result should be corrected for density (unknown)
BSA for Protein Quantitation (USP Reference Standard)
• Label concentration: 2.00 mg/mL (unknown accuracy, determined on basis of UV
280nm absorption)
• Found: 1.96 mg/mL (RSD = 0.4 %, n=3)
• Recovery: 98.0 % (vs. label concentration)
30. 30Arnaud Delobel, PhD – Webinar Quality Assistance – May 23rd 2019
Conclusions
• The method characteristics are:
▪ Good sensitivity: 1 or 2 mg of protein in 5 mL is enough
▪ High reproducibility: RSD < 1 %
▪ Great accuracy: < 2 % bias
▪ Insensitivity to matrix effect
▪ Same method for any protein or peptide
▪ Uses only very common reagents and standards
▪ Fast: results obtained within half a day of lab work in routine use
• It is suitable for:
▪ Assay of a single protein or mAb in solution
▪ Assay of a protein adsorbed on an adjuvant (vaccines)
▪ Accurate determination of a protein or peptide standard solution concentration
▪ Determination of the molar extinction coefficient
• Excellent orthogonal method to colorimetry, AAA, theoretical molar extinction
coefficient
31. 31Arnaud Delobel, PhD – Webinar Quality Assistance – May 23rd 2019
Comparison of protein quantification methods not requiring
the reference protein
Colorimetry
Extinct. coeff.
(calculated)
Amino Acids
Analysis
Sulfur by
ICP-MS
Single protein Yes Yes Yes Yes
Need for a standard
protein
Yes (BSA) No
No
(Amino Acids)
No
(Sulfate sol.)
Bias Significant
Can be
significant
5 - 10 % < 2 %
Precision (% RSD) > 5 % N/A > 5 % < 1 %
Interferences Yes
Yes
(ex: ADC)
No No
32. 32Arnaud Delobel, PhD – Webinar Quality Assistance – May 23rd 2019
How to apply the method to ADCs?
• If the drug/linker contains no sulphur: easy!
• If the drug/linker contains sulphur:
Determination
of DAR by LC/MS Calculation of mean number
of sulphur atoms per ADC
ICP-MS/MS analysis and
determination of ADC
concentration
33. 33Arnaud Delobel, PhD – Webinar Quality Assistance – May 23rd 2019
Take-Home Messages
AAA is no longer the
reference method for
absolute quantification of
proteins
You no longer have to
accept > 10%
uncertainty in your
extinction coefficient
determination
Our ICP/MS method was
validated and showed
excellent precision and
accuracy
(RSD < 1%, bias < 2%)
The method can be
applied on a wide range
of formulations without
further optimisation The method can be run
in a full GMP
environment
34. 34Arnaud Delobel, PhD – Webinar Quality Assistance – May 23rd 2019
Acknowledgements
• Juliusz Bianga
• Damien Mouvet
• Philippe De Raeve
35. 35Arnaud Delobel, PhD – Webinar Quality Assistance – May 23rd 2019
arnaud.delobel@quality-assistance.be
+32 71 53 47 81
www.quality-assistance.com
Technoparc de Thudinie, 2
B-6536 Donstiennes (Belgium)
Thank you for
your attention
Any question?